SK Bioscience Shares Real-World Vaccine Evidence with Healthcare Professionals
SKY Vision Symposium Held in Suwon and Busan
SK Bioscience has re-highlighted the clinical value of its independently developed vaccines by sharing real-world evidence (RWE) with healthcare professionals nationwide.
SK Bioscience announced that it hosted the 'SKY Vision Symposium,' an academic event for medical professionals, at the Ramada Hotel in Suwon, Gyeonggi Province on July 14 and at the Lotte Hotel in Seomyeon, Busan on July 28.
Yusuan, Head of Domestic Marketing at SK Bioscience, is delivering a greeting to the attendees while hosting a symposium. SK Bioscience
View original imageAt this symposium, the company presented the latest clinical research findings and real-world evidence accumulated in actual healthcare settings for its flu vaccine 'SKYCellflu,' shingles vaccine 'SKYZoster,' and RSV preventive antibody drug 'Beyfortus.'
With the flu, RSV, and shingles season approaching, the company has been recognized for expanding evidence-based vaccination strategies and demonstrating its competitiveness as a specialized vaccine company through active academic exchange.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Yoo Suan, Head of Domestic Marketing at SK Bioscience, stated, "We will continue to provide evidence-based information through ongoing academic exchange, contributing to public health promotion and the advancement of Korea's immunization environment."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.